Trials that use: Covariate adjustment
5,848 results
- GEMINI LTSIndependent statistical analysis of An Open-label Study of Vedolizumab (MLN0002) in Participants With Ulcerative Colitis and Crohn's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- GEMINI Study – A Study of Saquinavir/Ritonavir in Treatment-Naive Patients With HIV-1 Infection: Complete Statistical AnalysisIndependent statistical analysis of GEMINI Study - A Study of Saquinavir/Ritonavir in Treatment-Naive Patients With HIV-1 Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Gene Signatures of Influenza Vaccine Responses in Older Adults: Complete Statistical AnalysisIndependent statistical analysis of Gene Signatures of Influenza Vaccine Responses in Older Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03603509).
- Gene Therapy for X-linked Retinitis Pigmentosa (XLRP) – Retinitis Pigmentosa GTPase Regulator (RPGR): Complete Statistical AnalysisIndependent statistical analysis of Gene Therapy for X-linked Retinitis Pigmentosa (XLRP) - Retinitis Pigmentosa GTPase Regulator (RPGR): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD: Complete Statistical AnalysisIndependent statistical analysis of Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- General Anesthesia With ETT vs LMA in Patients Undergoing Ablation for Atrial Fibrillation: Complete Statistical AnalysisIndependent statistical analysis of General Anesthesia With ETT vs LMA in Patients Undergoing Ablation for Atrial Fibrillation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Genetic and Brain Mechanisms of Naltrexone’s Treatment Efficacy for Alcoholism: Complete Statistical AnalysisIndependent statistical analysis of Genetic and Brain Mechanisms of Naltrexone's Treatment Efficacy for Alcoholism: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00920829).
- Genetic and Molecular Mechanisms in Assessing Response in Patients With Prostate Cancer Receiving Enzalutamide Therapy: Complete Statistical AnalysisIndependent statistical analysis of Genetic and Molecular Mechanisms in Assessing Response in Patients With Prostate Cancer Receiving Enzalutamide Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Genetic and Neural Factors in Alcohol-Related Cognition: Complete Statistical AnalysisIndependent statistical analysis of Genetic and Neural Factors in Alcohol-Related Cognition: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03725345).
- Genetic Basis for Variation in the Renal Elimination of Metformin: Complete Statistical AnalysisIndependent statistical analysis of Genetic Basis for Variation in the Renal Elimination of Metformin: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00187720).
- Genetic Effects on Dopamine Response to an Opiate: Complete Statistical AnalysisIndependent statistical analysis of Genetic Effects on Dopamine Response to an Opiate: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01878006).
- GeniProIndependent statistical analysis of Genistein Supplementation to Mitigate Cardiometabolic Dysfunction in Patients Undergoing Androgen Deprivation Therapy for Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Genotype-supported Versus Conventional Proton Pump Inhibitor Dosing: Complete Statistical AnalysisIndependent statistical analysis of Genotype-supported Versus Conventional Proton Pump Inhibitor Dosing: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02930824).
- Gentamicin Bladder Instillations to Prevent Urinary Tract Infections in Patients With Spinal Cord Injury: Complete Statistical AnalysisIndependent statistical analysis of Gentamicin Bladder Instillations to Prevent Urinary Tract Infections in Patients With Spinal Cord Injury: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- GeoScan and Remote Geo Smoking Study: Neural and Behavioral Correlates of Smokers’ Exposure to Retail Environments: Complete Statistical AnalysisIndependent statistical analysis of GeoScan and Remote Geo Smoking Study: Neural and Behavioral Correlates of Smokers' Exposure to Retail Environments: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Geriatric Ketamine for Pain Management Study: Complete Statistical AnalysisIndependent statistical analysis of Geriatric Ketamine for Pain Management Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02673372).
- Gestational Weight Gain and Postpartum Weight Loss in Active Duty Women (Moms Fit 2 Fight): Complete Statistical AnalysisIndependent statistical analysis of Gestational Weight Gain and Postpartum Weight Loss in Active Duty Women (Moms Fit 2 Fight): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- GETGOAL-L-ASIAIndependent statistical analysis of GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Basal Insulin +/- Sulfonylurea (GETGOAL-L-ASIA): primary endpoint results, effect…
- GETGOAL-MONOIndependent statistical analysis of GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation in Monotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- GETUGV04Independent statistical analysis of A Phase II Trial Evaluating an Organ-conserving Strategy by Radiochemotherapy for Muscle-infiltrative Bladder Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- GINGERIndependent statistical analysis of Ginger's Therapeutic Potential in Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03705832).
- Girls on the Move Intervention to Increase Physical Activity Among Middle School Girls: Complete Statistical AnalysisIndependent statistical analysis of Girls on the Move Intervention to Increase Physical Activity Among Middle School Girls: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Glargine Dosing in Hospitalized Patients With Type 2 Diabetes and Renal Insufficiency: Complete Statistical AnalysisIndependent statistical analysis of Glargine Dosing in Hospitalized Patients With Type 2 Diabetes and Renal Insufficiency: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- GLEAMIndependent statistical analysis of A Trial to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Participants With Diabetic Macular Edema (DME): primary endpoint results, effect estimate with confidence…
- GLIDERIndependent statistical analysis of A Study Evaluating the Effects of GLPG3970 Given as an Oral Treatment for 12 Weeks in Adults With Active Primary Sjögren's Syndrome (pSS): primary endpoint results, effect estimate…
- GlideScope Versus Direct Laryngoscope for Emergency Intubation: Complete Statistical AnalysisIndependent statistical analysis of GlideScope Versus Direct Laryngoscope for Emergency Intubation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01235065).
- GlideScope Video Laryngoscope Versus Fiberoptic Intubation: Complete Statistical AnalysisIndependent statistical analysis of GlideScope Video Laryngoscope Versus Fiberoptic Intubation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01091948).
- GLIMPIndependent statistical analysis of Effects of GLP1-RA on Ectopic Fat Deposition in Chronic Kidney Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- GLITTER 2Independent statistical analysis of Gan & Lee Insulin Glargine Target Type (2) Evaluating Research: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03371108).
- Global Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Women With Moderate to Severe Endometriosis-associated Pain: Complete Statistical AnalysisIndependent statistical analysis of Global Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Women With Moderate to Severe Endometriosis-associated Pain: primary endpoint results, effect estimate with confidence interval, sample-size…
- Glottic View Using Supraglottic Devices in Pediatric Patients: Complete Statistical AnalysisIndependent statistical analysis of Glottic View Using Supraglottic Devices in Pediatric Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02532465).
- GLS-1027 for the Prevention of Severe Pneumonitis Caused by SARS-CoV-2 Infection (COVID-19): Complete Statistical AnalysisIndependent statistical analysis of GLS-1027 for the Prevention of Severe Pneumonitis Caused by SARS-CoV-2 Infection (COVID-19): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- GLS-5700 in Dengue Virus-Naïve Adults: Complete Statistical AnalysisIndependent statistical analysis of GLS-5700 in Dengue Virus-Naïve Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02809443).
- Glucagon Response to Prandial Insulin Administration in Persons With Type 1 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Glucagon Response to Prandial Insulin Administration in Persons With Type 1 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Glucose Regulation in Acute Stroke Patients (GRASP) Study: Complete Statistical AnalysisIndependent statistical analysis of Glucose Regulation in Acute Stroke Patients (GRASP) Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00282867).
- Glucose Variability in Type 1 Diabetes (T1D) and Glycaemic Responses to Food Composition.: Complete Statistical AnalysisIndependent statistical analysis of Glucose Variability in Type 1 Diabetes (T1D) and Glycaemic Responses to Food Composition.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- GlulipidIndependent statistical analysis of Glucose and Lipid Metabolism on Antipsychotic Medication: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00515723).
- Glutathione Metabolism in Adolescents With Type 1 Diabetes – Study A: Complete Statistical AnalysisIndependent statistical analysis of Glutathione Metabolism in Adolescents With Type 1 Diabetes - Study A: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Glycemic Efficacy and Renal Safety Study of Dapagliflozin in Subjects With Type 2 Diabetes Mellitus and Moderate Renal Impairment: Complete Statistical AnalysisIndependent statistical analysis of Glycemic Efficacy and Renal Safety Study of Dapagliflozin in Subjects With Type 2 Diabetes Mellitus and Moderate Renal Impairment: primary endpoint results, effect estimate with confidence interval, sample-size…
- GMTIndependent statistical analysis of Neonatal Gastro-Esophageal Reflux Disease (GERD) Management Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02486263).
- Golimumab in Rheumatoid Arthritis Participants With an Inadequate Response to Etanercept (ENBREL) or Adalimumab (HUMIRA): Complete Statistical AnalysisIndependent statistical analysis of Golimumab in Rheumatoid Arthritis Participants With an Inadequate Response to Etanercept (ENBREL) or Adalimumab (HUMIRA): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- GOLMePsAIndependent statistical analysis of GOLimumab and Methotrexate Versus Methotrexate in Very Early PsA: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04108468).
- GORE® VIABAHN® Endoprosthesis Post-Marketing Surveillance Study (JPS 16-03): Complete Statistical AnalysisIndependent statistical analysis of GORE® VIABAHN® Endoprosthesis Post-Marketing Surveillance Study (JPS 16-03): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04706273).
- Gown and Glove Use to Prevent the Spread of Infection in VA Community Living Centers: Complete Statistical AnalysisIndependent statistical analysis of Gown and Glove Use to Prevent the Spread of Infection in VA Community Living Centers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- GRACE: A Study to Compare the Effectiveness, Safety and Tolerability of PREZISTA (Darunavir)/Ritonavir by Gender and Race When Administered With Other Antiretroviral Medications in Human Immunodeficiency Virus (HIV) Positive Women and Men.: Complete Statistical AnalysisIndependent statistical analysis of GRACE: A Study to Compare the Effectiveness, Safety and Tolerability of PREZISTA (Darunavir)/Ritonavir by Gender and Race When Administered With Other Antiretroviral Medications in Human Immunodeficiency Virus (HIV)…
- GRAND-307Independent statistical analysis of Study to Evaluate the Efficacy and Safety of Daily Oral TAK-875 25 and 50mg in Asia Pacific Adults With Type 2 Diabetes: primary endpoint results, effect estimate with…
- GRAVITYIndependent statistical analysis of 12-week Open-label, Phase IIIb Comparing Efficacy and Safety of Rosuvastatin (CRESTOR™) in Combination With Ezetimibe: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Grazoprevir (MK-5172) and Elbasvir (MK-8742) Combination for Chronic Hepatitis C Virus (HCV) Genotypes 1, 4, and 6 (MK-5172-065): Complete Statistical AnalysisIndependent statistical analysis of Grazoprevir (MK-5172) and Elbasvir (MK-8742) Combination for Chronic Hepatitis C Virus (HCV) Genotypes 1, 4, and 6 (MK-5172-065): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- GRC00097Independent statistical analysis of Collection of Serum Samples From Children and Older Adults Receiving the 2019-2020 Formulations of Fluzone® Quadrivalent and Fluzone® High-Dose Influenza Vaccines, Respectively: primary endpoint results, effect estimate with…
- GReaTIndependent statistical analysis of Gene Regulation by Thiazolidinediones: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00567593).